{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:45:10Z","timestamp":1776768310580,"version":"3.51.2"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure: European Journal of Epilepsy"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.seizure.2025.10.008","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T22:54:18Z","timestamp":1760223258000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Efficacy and safety of vigabatrin as preventive therapy for children with tuberous sclerosis complex: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"133","author":[{"given":"Nagita","family":"Devi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pooja","family":"Soni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8526-4691","authenticated-orcid":false,"given":"Priyanka","family":"Madaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3360-3153","authenticated-orcid":false,"given":"Indrasish Ray","family":"Chaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8183-5899","authenticated-orcid":false,"given":"Vaishakh","family":"Anand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4520-3293","authenticated-orcid":false,"given":"Dipika","family":"Bansal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5194-9951","authenticated-orcid":false,"given":"Jitendra Kumar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kollencheri Puthenveettil","family":"Vinayan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheffali","family":"Gulati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.seizure.2025.10.008_bib0001","unstructured":"Northrup H, Koenig MK, Pearson DA, et al. Tuberous sclerosis complex. 1999 Jul 13 [Updated 2024 Aug 1]. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews\u00ae [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2025."},{"key":"10.1016\/j.seizure.2025.10.008_bib0002","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.pediatrneurol.2013.08.002","article-title":"International Tuberous Sclerosis Complex Consensus Group. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 International Tuberous Sclerosis Complex Consensus Conference","volume":"49","author":"Krueger","year":"2013","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0003","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2021.07.011","article-title":"International Tuberous Sclerosis Complex Consensus Group. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations","volume":"123","author":"Northrup","year":"2021","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0004","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1136\/archdischild-2019-317218","article-title":"Tuberous sclerosis and cutaneous stigmata: ever-expanding spectrum","volume":"105","author":"Madaan","year":"2020","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.seizure.2025.10.008_bib0005","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0049475520972523","article-title":"Forehead plaque in a child with epilepsy: A clue for tuberous sclerosis","volume":"51","author":"Singanamalla","year":"2021","journal-title":"Trop Doct"},{"key":"10.1016\/j.seizure.2025.10.008_bib0006","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/epi4.12286","article-title":"TOSCA Consortium and TOSCA Investigators. Epilepsy in tuberous sclerosis complex: findings from the TOSCA Study","volume":"4","author":"Nabbout","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2025.10.008_bib0007","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14737175.2023.2216385","article-title":"Efficacy and safety of vigabatrin in patients with tuberous sclerosis complex and infantile epileptic spasm syndrome: a systematic review","volume":"23","author":"Prezioso","year":"2023","journal-title":"Expert Rev Neurother"},{"key":"10.1016\/j.seizure.2025.10.008_bib0008","article-title":"The landscape of infantile epileptic spasms syndrome in South Asia: peculiarities, challenges, and way forward","volume":"12","author":"Sahu","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/j.seizure.2025.10.008_bib0009","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s13312-021-2097-6","article-title":"Association of Child Neurology (AOCN) - Indian Epilepsy Society (IES) Consensus Guidelines for the Diagnosis and Management of West Syndrome","volume":"58","author":"Sharma","year":"2021","journal-title":"Indian Pediatr"},{"key":"10.1016\/j.seizure.2025.10.008_bib0010","unstructured":"Carson RSRP. Vigabatrin: StatPearls [Internet]; 2024 [Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK557579\/."},{"key":"10.1016\/j.seizure.2025.10.008_bib0011","article-title":"Early treatment with Vigabatrin does not decrease focal seizures or improve cognition in tuberous sclerosis complex: the PREVeNT trial","volume":"10","author":"Bebin","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0012","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.25956","article-title":"Prevention of epilepsy in infants with tuberous sclerosis complex in the EPISTOP trial","volume":"89","author":"Kotulska","year":"2021","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0013","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.seizure.2025.10.008_bib0014","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pediatrneurol.2019.07.008","article-title":"Preventive antiepileptic treatment in tuberous sclerosis complex: A long-term, prospective trial","volume":"101","author":"Jozwiak","year":"2019","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.spen.2024.101150","article-title":"Genetic principles related to neurocutaneous disorders","volume":"51","author":"Ferrante","year":"2024","journal-title":"Semin Pediatr Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0016","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.697467","article-title":"TOSCA Consortium and TOSCA Investigators. Historical patterns of diagnosis, treatments and ouctomes of epilepsy associated with tuberous sclerosis: results from TOSCA Registry","volume":"12","author":"Nabbout","year":"2021","journal-title":"Front Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0017","first-page":"603","article-title":"TOSCA Investigators. Tuberous sclerosis complex associated neuropsychiatric disorder (TAND): new findings on age, sex, and genotype in relation to intellectual phenotype","volume":"11","author":"de Vries","year":"2020","journal-title":"Front Neurol"},{"issue":"25","key":"10.1016\/j.seizure.2025.10.008_bib0018","first-page":"00002","article-title":"Brain related sexual dimorphism in tuberous sclerosis complex: an overlooked matter","volume":"S1471-4914","author":"Pais","year":"2025","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.seizure.2025.10.008_bib0019","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.seizure.2016.11.021","article-title":"Epileptic spasms-175years on: trying to teach an old dog new tricks","volume":"44","author":"Wilmshurst","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2025.10.008_bib0020","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/epi4.12419","article-title":"Management practices for West syndrome in South Asia: A survey study and meta-analysis","volume":"5","author":"Madaan","year":"2020","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.seizure.2025.10.008_bib0021","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s12098-021-03918-y","article-title":"Epilepsy and neurodevelopmental outcomes in a cohort of West syndrome beyond two years of age","volume":"89","author":"Aramanadka","year":"2021","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.seizure.2025.10.008_bib0022","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s12098-020-03521-7","article-title":"Safety, feasibility and effectiveness of pulse methylprednisolone therapy in comparison with intramuscular adrenocorticotrophic hormone in children with West syndrome","volume":"88","author":"Rajpurohit","year":"2021","journal-title":"Indian J Pediatr"},{"key":"10.1016\/j.seizure.2025.10.008_bib0023","doi-asserted-by":"crossref","DOI":"10.1097\/WCO.0000000000001256","article-title":"Prevention of epileptogenesis- are we there yet?","author":"Koepp","year":"2024","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0024","article-title":"Commentary regarding the results of the PREVENT and EPISTOP trials","author":"Jozwiak","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/15357597231225097","article-title":"Vigabatrin in epilepsy related to TSC: does it PREVeNT AND OR (EPI)STOP seizures OR.. Do we need some more STEPS as VI RAP?","volume":"24","author":"Joshi","year":"2024","journal-title":"Epilepsy Curr"},{"key":"10.1016\/j.seizure.2025.10.008_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.braindev.2025.104322","article-title":"Intellectual disability and autistic behaviors and their modifying factors in children with Tuberous sclerosis complex","volume":"47","author":"Jozwiak","year":"2025","journal-title":"Brain Dev"},{"key":"10.1016\/j.seizure.2025.10.008_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1436061","article-title":"Neuropsychiatric profile in tuberous sclerosis complex patients with epilepsy","volume":"12","author":"Osman","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/j.seizure.2025.10.008_bib0028","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1111\/epi.17507","article-title":"Epilepsy severity mediates association between mutation type and ADHD symptoms in tuberous sclerosis complex","volume":"64","author":"Tye","year":"2023","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2025.10.008_bib0029","doi-asserted-by":"crossref","first-page":"187.e1","DOI":"10.1016\/j.jaapos.2022.05.001","article-title":"Ocular examinations, findings, and toxicity in children taking vigabatrin","volume":"26","author":"Schein","year":"2022","journal-title":"J AAPOS"},{"key":"10.1016\/j.seizure.2025.10.008_bib0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/dmcn.15099","article-title":"Visual field defects after vigabatrin treatment during infancy: retrospective population based study","volume":"64","author":"Jonsson","year":"2022","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/j.seizure.2025.10.008_bib0031","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1080\/14737175.2020.1840356","article-title":"Vigabatrin-related adverse events for the treatment of epileptic spasms: systematic review and meta-analysis","volume":"20","author":"Biswas","year":"2020","journal-title":"Expert Rev Neurother"}],"container-title":["Seizure: European Journal of Epilepsy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131125002766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T08:06:14Z","timestamp":1765094774000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131125002766"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":31,"alternative-id":["S1059131125002766"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2025.10.008","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of vigabatrin as preventive therapy for children with tuberous sclerosis complex: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Seizure: European Journal of Epilepsy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2025.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 British Epilepsy Association. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}